172 related articles for article (PubMed ID: 38286463)
1. Impact of different genetic mutations on granulocyte development and G-CSF responsiveness in congenital neutropenia.
Meng X; Zhang H; Dong L; Min Q; Yu M; Li Y; Liu L; Wang W; Ying W; Sun J; Wang JY; Hou J; Wang X
Blood Adv; 2024 Apr; 8(7):1667-1682. PubMed ID: 38286463
[TBL] [Abstract][Full Text] [Related]
2. Congenital neutropenia: From lab bench to clinic bedside and back.
Dobrewa W; Bielska M; Bąbol-Pokora K; Janczar S; Młynarski W
Mutat Res Rev Mutat Res; 2024; 793():108476. PubMed ID: 37989463
[TBL] [Abstract][Full Text] [Related]
3. Functional characteristics of circulating granulocytes in severe congenital neutropenia caused by ELANE mutations.
Liu Q; Sundqvist M; Li W; Holdfeldt A; Zhang L; Björkman L; Bylund J; Dahlgren C; Wang C; Zhao X; Forsman H
BMC Pediatr; 2019 Jun; 19(1):189. PubMed ID: 31176364
[TBL] [Abstract][Full Text] [Related]
4. A zebrafish model for HAX1-associated congenital neutropenia.
Doll L; Aghaallaei N; Dick AM; Welte K; Skokowa J; Bajoghli B
Haematologica; 2021 May; 106(5):1311-1320. PubMed ID: 32327498
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis and clinical picture of severe congenital neutropenia in Israel.
Lebel A; Yacobovich J; Krasnov T; Koren A; Levin C; Kaplinsky C; Ravel-Vilk S; Laor R; Attias D; Ben Barak A; Shtager D; Stein J; Kuperman A; Miskin H; Dgany O; Giri N; Alter BP; Tamary H
Pediatr Blood Cancer; 2015 Jan; 62(1):103-8. PubMed ID: 25284454
[TBL] [Abstract][Full Text] [Related]
6. Congenital Neutropenia Patient With Hypomorphic Biallelic CSF3R Mutation Responding to GCSF.
Yilmaz Karapinar D; Akinci B; Şahin Yaşar A; Hekimci Özdemir H; Önder Siviş Z; Onay H; Özkinay F
J Pediatr Hematol Oncol; 2019 Apr; 41(3):e190-e192. PubMed ID: 30028820
[TBL] [Abstract][Full Text] [Related]
7. Severe congenital neutropenias.
Skokowa J; Dale DC; Touw IP; Zeidler C; Welte K
Nat Rev Dis Primers; 2017 Jun; 3():17032. PubMed ID: 28593997
[TBL] [Abstract][Full Text] [Related]
8. Severe congenital neutropenia, SRP54 pathogenicity, and a framework for surveillance.
Fan EM; Vagher J; Meznarich JA; Ubico EM; Goteti S; Peterson D; Rayes A; Maese LD
Am J Med Genet A; 2023 May; 191(5):1434-1441. PubMed ID: 36815775
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of severe congenital neutropenia caused by novel ELANE gene mutations.
Shu Z; Li XH; Bai XM; Zhang ZY; Jiang LP; Tang XM; Zhao XD
Pediatr Infect Dis J; 2015 Feb; 34(2):203-7. PubMed ID: 25162927
[TBL] [Abstract][Full Text] [Related]
10. PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations.
Olofsen PA; Bosch DA; Roovers O; van Strien PMH; de Looper HWJ; Hoogenboezem RM; Barnhoorn S; Mastroberardino PG; Ghazvini M; van der Velden VHJ; Bindels EMJ; de Pater EM; Touw IP
Blood Adv; 2021 Feb; 5(3):775-786. PubMed ID: 33560392
[TBL] [Abstract][Full Text] [Related]
11. Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring
Zeidler A; Borbaran-Bravo N; Dannenmann B; Ritter M; Nasri M; Klimiankou M; Kandabarau S; Zahabi A; König J; Zeidler C; Skokowa J; Welte K
Haematologica; 2024 May; 109(5):1393-1402. PubMed ID: 37855057
[TBL] [Abstract][Full Text] [Related]
12. Severe congenital neutropenia in two siblings related to HAX1 mutation without neurodevelopmental disorders.
Patiroglu T; Gungor HE; Triot A; Unal E
Genet Couns; 2013; 24(3):253-8. PubMed ID: 24341138
[TBL] [Abstract][Full Text] [Related]
13. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
McLemore ML; Poursine-Laurent J; Link DC
J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Association between cyclic neutropenia and SRP54 deficiency.
Erdős M; Boyarchuk O; Maródi L
Front Immunol; 2022; 13():975017. PubMed ID: 36159802
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous M1V variant of ELA-2 gene mutation associated with G-CSF refractory severe congenital neutropenia.
Setty BA; Yeager ND; Bajwa RP
Pediatr Blood Cancer; 2011 Sep; 57(3):514-5. PubMed ID: 21618407
[TBL] [Abstract][Full Text] [Related]
16. Severe congenital neutropenia: abnormal growth and differentiation of myeloid progenitors to granulocyte colony-stimulating factor (G-CSF) but normal response to G-CSF plus stem cell factor.
Hestdal K; Welte K; Lie SO; Keller JR; Ruscetti FW; Abrahamsen TG
Blood; 1993 Nov; 82(10):2991-7. PubMed ID: 7693032
[TBL] [Abstract][Full Text] [Related]
17. Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis.
McDermott DH; De Ravin SS; Jun HS; Liu Q; Priel DA; Noel P; Takemoto CM; Ojode T; Paul SM; Dunsmore KP; Hilligoss D; Marquesen M; Ulrick J; Kuhns DB; Chou JY; Malech HL; Murphy PM
Blood; 2010 Oct; 116(15):2793-802. PubMed ID: 20616219
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia.
Zeidler C; Germeshausen M; Klein C; Welte K
Br J Haematol; 2009 Feb; 144(4):459-67. PubMed ID: 19120359
[TBL] [Abstract][Full Text] [Related]
19. Inducible expression of a disease-associated
Garg B; Mehta HM; Wang B; Kamel R; Horwitz MS; Corey SJ
J Biol Chem; 2020 May; 295(21):7492-7500. PubMed ID: 32299910
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia.
Nasri M; Ritter MU; Mir P; Dannenmann B; Kaufmann MM; Arreba-Tutusaus P; Xu Y; Borbaran-Bravo N; Klimiankou M; Lengerke C; Zeidler C; Cathomen T; Welte K; Skokowa J
Mol Ther; 2024 Jun; 32(6):1628-1642. PubMed ID: 38556793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
